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The Hyper-immunoglobulin M syndromes (HIGM) are a heterogeneous group of genetic disorders resulting in
defects of immunoglobulin class switch recombination. Affected patients show humoral immunodeficiency and
high susceptibility to opportunistic infections. Elevated serum IgM levels are the hallmark of the disease, even
though in few rare cases they may be in the normal range. Hyper IgM is associated with low to undetectable levels
of serum IgG, IgA, and IgE. In some cases, alterations in different genes may be identified. Mutations in five genes
have so far been associated to the disease, which can be inherited with an X-linked (CD40 ligand, and nuclear
factor-kB essential modulator defects) or an autosomal recessive (CD40, activation-induced cytidine deaminase, and
uracil-DNA glycosylase mutation) pattern. The patient herein described presented with recurrent upper and lower
respiratory infections and evidence of suppurative lung disease at the conventional chest imaging. The presence of
low serum IgG and IgA levels, elevated IgM levels, and a marked reduction of in vivo switched memory B cells led
to a clinical and functional diagnosis of HIGM although the genetic cause was not identified.Background
Chronic suppurative lung disease (CSLD) describes a
clinical syndrome characterized by chronic endobron-
chial suppuration with or without high resolution com-
puted tomography (HRCT) evidence of bronchiectasis
[1,2]. The presenting symptoms are identical to bronchi-
ectasis, and include recurrent chest infections with pro-
longed moist or productive cough, exertional dyspnoea,
features of reactive airway disease, and in some cases
growth failure. Digital clubbing, chest wall deformity, ad-
ventitious sounds, and/or hyperinflation are the main
physical signs. Haemoptysis is rare in children. Once
excluded cystic fibrosis (CF), patients should be investi-
gated for other disorders, such as primary immunodefi-
ciencies, aspiration pneumonia, and primary ciliary
dyskinesia (PCD) [3].
Hyper-immunoglobulin M syndrome (HIGM) is a rare
(incidence, 1 in 100,000 births) primary immunodefi-
ciency [4,5], in which defective B cell isotype switching
leads to a phenotype characterized by elevated or normal
levels of serum IgM, and low levels of serum IgG, IgA* Correspondence: santamar@unina.it
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reproduction in any medium, provided the orand IgE [5]. Mutations in five different genes, encoding
for CD40 ligand, CD40, nuclear factor-kB essential
modulator (NEMO), activation-induced cytidine deami-
nase (AID), and uracil-DNA glycosylase (UNG), have so
far been associated to the disease [6-8]. Like in other
humoral immunodeficiencies, recurrent respiratory tract
infections, potentially leading to bronchiectasis, sinus
infections, and ear infections are commonly found in
affected patients. Immunoglobulin replacement therapy
prevents the progression of the clinical manifestations.
In around 40% of cases opportunistic infections by
Pneumocystis carinii is the presenting feature of the syn-
drome [9,10]. However, despite the high susceptibility to
airway infections, lung involvement is not commonly
characterized by CSLD.
We herein describe the case of a 7-year old girl pre-
senting with symptoms and signs of CSLD, in whom a
functional and clinical diagnosis of HIGM was achieved.Case presentation
A 7-year old girl complaining of recurrent upper and
lower respiratory infections and chronic productive
cough was referred to our Department for further diag-
nostic work-up. She was born to non-consanguineousal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been healthy until the age of three years, when recurrent
upper respiratory tract infections started. No other pro-
blems were experienced by the patient until the age of
6 years, when she developed an acute pneumonia during
a measles infection. Since then, recurrent lower airway
infections requiring repeated antibiotic courses and sev-
eral hospital admissions occurred.
At admission to our Department, the patient appeared
in good clinical conditions and physical respiratory
examination disclosed any remarkable sign except for
mild rhinorrhea and productive cough. Lung ausculta-
tion revealed diffuse mild crackles and rhonchi. No
symptoms and signs of heart disease were observed.
Lung function tests showed no relevant impairment, with
forced expiratory volume in 1 second (FEV1) and forced
vital capacity (FVC) of 106% and 104% predicted, re-
spectively. Bronchiectasis in the left and right lower lobes
and a consolidation area in the middle lobe were evident
at chest HRCT (Figure 1). Tuberculosis, CF, PCD, gas-
troesophageal reflux disease, alpha-1 anti-trypsin defi-
ciency and atopy were ruled out on the basis of normal
or negative results of purified protein derivative test,
sweat test, cilia motility and ultrastructure assessment at
nasal brushing, prolonged pH-metry, serum alpha-1
anti-trypsin level, and skin prick test and serum IgE
levels to the most common food and inhalant allergens.
General blood test results were unremarkable, but raised
levels of serum IgM (5.63 g/l; normal range, 0.56-2.61)
associated with low serum concentration of IgG and IgA
(6.06 g/l; normal age-matched range, 6.33-10.16; and
0.33 g/l; normal range, 0.41-3.15, respectively) suggested
the diagnosis of HIGM, supported by a marked reduc-
tion of in vivo switched memory B cells.
The lymphocyte immunophenotyping was assessed by
flow cytometry. For flow cytometry analysis, the samples
were incubated at 4°C for 20 minutes with the appropri-
ate amount of monoclonal antibodies, following the
manufacturer’s instructions. The mixtures were lysed
with ammonium chloride (NH4Cl) lysing solution, thenFigure 1 Chest HRCT: bronchiectasis in the left and right lower lobes
observed.incubated at room temperature for 10 minutes, and fi-
nally washed with phosphate buffered saline. Samples
were then acquired on a FACSCanto II flow cytometer
and analysed with FACSDiva software (BD Bioscience).
Fluorescein isothiocyanate-, phycoerythrin-, and peridin
chlorophyll protein-coupled antibodies to the following
cell-surface proteins were used for flow cytometry:
CD19, CD45RA, CD27 (BD Pharmingen or Beckman
Coulter) [11]. Results revealed an increase in CD19+
cells (44%), with complete lack of switched CD27+ B
cells. Naïve T cells (CD45RA+) were normally found, but
CD40-L expression on T lymphocytes after proper
stimulation was low (0.2%), indicating a functional alter-
ation of the machinery required for immunoglobulin
class switch recombination (CSR). To rule out a non-
random X-inactivation, responsible for a CD40-L defect
in a female, a methylation assay was performed as previ-
ously described [12], and was found normal. Sequence ana-
lysis of NEMO and TACI (transmembrane activator and
calcium-modulating cyclophilin ligand interactor) revealed
no alterations. The mutational analysis of NEMO and TACI
was carried out using the polymerase chain reaction test
as described by Bardaro et al. [13,14]. Amplification was
performed using specific primers for NEMO (forward-
GAGGACCAATACCGAGCATC and JF3R reverse primers)
and TACI (forward-GTGGTCACTTATTCTAAAGG and
reverse-GCAGGATCTTGCCTGCGTC primers). Ampli-
fied products were automatically sequenced. ABI Prism
dye terminator cycle sequencing kit and an ABI 377 Auto-
mated DNA Sequencer were used.
Treatment including daily physiotherapy with nebu-
lized saline was started. Prolonged oral and/or intra-
venous antibiotics decided on the basis of sputum
culture results were prescribed when required. During
the follow-up, predominantly Streptococcus pneumoniae
and Haemophilus influenzae were isolated at sputum cul-
tures performed on a three-monthly basis. Mycoplasma
pneumoniae infection was diagnosed at the age of
11 years. Overall, after the first pneumonia occurred dur-
ing measles, she had 7 more episodes of chest X-ray(A) and a consolidation area in the middle lobe (B) may be
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developed a skin lesion on the neck and the histological
examination led to a diagnosis of cutaneous B-cells
lymphoma successfully treated with at the Oncologic
Department. Over the follow-up, the patient was visited
about every 3 months, and serum IgM concentration,
evaluated every 3-to-6 months, remained persistently
elevated, while the low IgG levels progressively
decreased over time eventually requiring, at the age of
12 years, the start of intravenous immunoglobulin re-
placement therapy because of serum IgG levels of
2.93 g/l (normal range, 6.40-19.09) (Figure 2). At
present, the patient is 16-year old. Her clinical condi-
tions are stable and daily physiotherapy with nebulised
saline is still ongoing. Intravenous immunoglobulin re-
placement therapy is performed approximately every
3 months.
Discussion
Hyper IgM syndrome is a heterogeneous group of im-
mune defects characterized by normal or increased pro-
duction of IgM contrasting with a marked decrease or
an absence of other isotypes (i.e., IgG, IgA, and IgE).
The humoral immunodeficiency results in susceptibility
to bacterial infections particularly affecting the respira-
tory tract. Patients with HIGM often present infections
by opportunistic intracellular pathogens, such as
Pneumocystis carinii [10,15], Cryptosporidium species
[16], Toxoplasma gondii [17], and Mycobacteria species
[18]. A common complication of both clinical and sub-
clinical infections is represented by cholangiopathy,
which may lead to the development of liver function
tests alterations, sclerosing cholangitis, and cirrhosis
that may eventually result in cholangiocarcinoma [16].
Chronic intestinal cryptosporidiosis may lead to weight












Figure 2 Immunoglobulin levels through the long-term follow-up: se
respectively, thus requiring intravenous immunoglobulin replacemenneurologic complications, such as cerebral toxoplasmo-
sis [19,20] and cryptococcosis [21], are seen in 10-to-
15% of affected males. Disseminated cytomegalovirus
infection may be observed as presenting sign [22].
Moreover, neutropenia may often complicate CD40-
ligand deficiency, while autoimmune complications are
relatively common in patients with defects of CD40 sig-
nalling. Malignancies may also occur in patients with
HIGM and usually affect the biliary tree [9,16] and the
gastrointestinal tract in the form of neuroendocrine
tumours [23]. As in other immunodeficiencies, patients
also have an increased risk for lymphomas, particularly
Hodgkin's disease associated with Epstein-Barr virus in-
fection [24,25]. Indeed, AID deficiency causes the most
frequent autosomal recessive alteration of CSR. Marked
lymphoid hypertrophy represent a clinical feature of
AID deficiency, even though malignant lymphoprolifera-
tion has not been ever described. Nevertheless, knock
out mice for the UNG gene are prone to B cell lymph-
omas [26]. Furthermore, lymphomas are common in
forms of HIGM due to DNA repair defects such as
Ataxia-telangiectasia and Nijmegen Breakage syndrome.
Allogeneic hematopoietic cell transplantation can be
curative and feasible for the X-linked forms of HIGM
without severe cryptosporidial infection and its related
complications. If available, transplantation from either
an HLA-matched sibling or an HLA-matched unrelated
donor can be performed safely [27].
Mutations in five different genes involved in CSR have
so far been associated with HIGM. X-linked forms are
due to alterations of CD40-ligand and NEMO genes,
while autosomal recessive forms are associated with
mutations in CD40, AID, and UNG genes. The first
recognized and most frequent form of HIGM, account-
ing for at least 70% of patients with CSR, is CD40-ligand








rum IgG and IgA progressively decreased to 2.93 g/l and 0.02 g/l,
t therapy.
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and UNG genes have not. However, we are planning to
search for these genetic alterations in the near future.
Specialist referral to diagnose CSLD/bronchiectasis is
recommended for children who have either two or more
episodes of chronic wet cough per year, or chest radio-
graphic abnormalities persisting for at least 6 weeks after
appropriate therapy [30]. In previous large series, the
majority of cases of CSLD appeared associated to extrin-
sic factors, especially childhood respiratory infections
(severe pneumonia, pertussis, complicated measles and
tuberculosis) that caused chronic endobronchial suppur-
ation with or without bronchiectasis. Singleton et al.
reviewed the case histories of 46 Alaskan native children
with bronchiectasis born in the 1970s, and concluded
that recurrent pneumonia was the major preceding med-
ical condition leading to bronchial damage [31]. In a
study by Eastham et al., previous pneumonia was the
most common cause found in 93 cases of non-CF bron-
chiectasis [32]. Likewise, nearly 50% of children were
found to have developed bronchiectasis after tubercu-
losis or severe pneumonia in a review study by Karakoc
et al. [33]. Nowadays, with early immunization and the
widespread use of antibiotics in childhood, post-
infectious damage is likely to be less relevant than in
non-vaccinated children [34]. Nonetheless, detailed
investigations must be carried out to determine the
underlying cause of the condition [35]. In CSLD, type,
extent and severity of lung changes is evaluated by chest
imaging techniques, including HRCT or magnetic reson-
ance imaging [2,36].
Our case report highlights the importance to search
for noninfectious extrinsic insults or intrinsic defects
that predispose to bronchial inflammation or infection
resulting in CSLD. These must include aspiration of irri-
tants and congenital disorders, as immunodeficiencies
and ciliary defects [37-39]. The identification of the
underlying disorder is mandatory in that a delayed diag-
nosis is associated with more severe disease [40].Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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